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Among the 7.9 million people living with HIV in South Africa (SA) 
in 2017, ~60% are women, with young women aged 15 - 24  years 
having an HIV incidence rate four times higher than males of 
the same age, highlighting the increasing ‘feminisation’ of the 
HIV epidemic.[1] Young women are particularly vulnerable to HIV 
infection and sexual and gender-based violence (SGBV), as many of 
them experience poverty and economic insecurity, and have limited 
sexual agency.[2] The degenerative impact of HIV/AIDS is profound, 
with multiple sexual partnerships, age-disparate relationships, 
inconsistent contraceptive use and stigma cited as the main drivers 
of the epidemic.[3]
SGBV itself is a risk factor for HIV. As a result of SGBV, women 
especially are vulnerable to HIV infection in complex and intertwined 
ways, ranging from coercive intimate-partner sexual intercourse 
without the use of a condom to rape. The World Health Organization 
(WHO) identified several direct and indirect SGBV-linked sources 
of HIV transmission: (i) direct transmission through sexual violence, 
including forced or coercive sexual intercourse with an HIV-infected 
partner; (ii) indirect transmission through sexual risk-taking, with 
studies supporting the theory that women’s experience of violence is 
linked to increased risk-taking, including having multiple partners or 
non-primary partners (or partnerships outside marriage), or engaging 
in transactional sex; (iii) indirect transmission through inability to 
negotiate condom use; (iv) indirect transmission by partnering with 
riskier/older men, sometimes leading to the use of violence in the 
process of negotiating condom use; and (v) SGBV as a consequence of 
being HIV-positive or fear of violence as a barrier to disclosure of HIV 
status among those women who do seek testing.[4] SGBV is therefore 
a risk factor for HIV infection, and HIV infection is a risk factor for 
SGBV. Although HIV infection as a consequence of violence against 
women is sufficiently covered by current research, serious gaps exist 
with respect to prevalence rates of SGBV among individuals seeking 
voluntary counselling and testing (VCT) services.[5-7]
Despite the clear mutually compounding link between HIV and 
SGBV, services for, and research on, SGBV have suffered from: 
(i) fractured and delayed health responses to women who have 
acquired HIV through sexual violence; (ii) lack of any prevalence 
rates of SGBV among individuals seeking HIV VCT services in SA; 
(iii) lack of availability of information and data to effectively inform 
programming, including poorly defined health ‘indicators’ for SGBV; 
and (iv) lack of coherent, systematic and reliable surveillance systems 
for SGBV data collection at VCT centres and HIV clinics. Currently, 
there is no comprehensive screening tool that screens women and 
men at VCT facilities for both intimate-partner violence and non-
intimate-partner sexual violence. One notable exception is the work of 
Hassen and Deyassa,[8] who examined both forms of violence among 
women using VCT services in South Wollo Zone, Ethiopia, and found 
a relationship between sexual violence and HIV infection. Using a 
modified WHO questionnaire, they studied the prevalence of lifetime 
sexual violence, lifetime intimate-partner violence and past 12 months 
intimate-partner violence, finding prevalence rates of 34.6%, 32.3% and 
10.5%, respectively. Both intimate-partner violence and lifetime sexual 
violence by another perpetrator were associated with HIV infection.
Other research investigating the link between sexual violence and 
HIV has generally been conducted on populations of sexual assault 
survivors who present at medicolegal facilities.[9] While this research 
explores sexual violence by both intimate partners and non-intimate 
partners, the populations under study are known sexual assault 
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survivors seeking medicolegal services – in other words, survivors 
who have officially reported a sexual assault. It is estimated, however, 
that only one in nine survivors of sexual violence reports the assault. 
Research done with survivors at medicolegal facilities may therefore 
underestimate the prevalence of SGBV. The WHO has identified that 
further research should assess whether and how asking women about 
intimate-partner violence in the context of HIV VCT is feasible.[10] 
The development of a rapid and reliable violence screening 
instrument at VCT facilities could play a significant role in identifying 
survivors of SGBV. Identifying survivors would allow HIV providers 
to recognise specific counselling or health needs of survivors, and 
thus to tailor their comprehensive HIV and general healthcare 
response, particularly to women.
Objectives
To assess levels of SGBV in a patient population of an HIV facility 
in SA.
Methods
Drawing on the methodology of Hassen and Deyassa,[8] we 
conducted a facility-based cross-sectional study on SGBV and HIV, 
which examined the incidence, prevalence and nature of intimate-
partner violence and non-intimate-partner sexual violence in the 
clinic population at the AIDS Healthcare Foundation (AHF) clinic 
in Umlazi, KwaZulu-Natal (KZN) Province. The clinic provides 
comprehensive HIV services to the general population, including 
VCT, HIV treatment, treatment literacy classes and adherence 
counselling. We screened all patients coming for VCT for SGBV. 
Additionally, we measured the prevalence of sexual violence among 
a group of patients participating in treatment literacy classes. We 
included women and men in the study in order to gain a more 
comprehensive picture of the extent and nature of SGBV among HIV 
testing and treatment patients more generally.
Instruments and sampling
The recruitment process involved a rigorous informed and voluntary 
consent process. We designed two instruments to complement the 
existing screening and assessment forms used by HIV counsellors and 
clinicians as part of current screening protocols. The survey consisted 
of two sections: (i) a brief screening questionnaire pertaining to the 
reasons for being tested, specifically asking about SGBV; and (ii) an 
anonymous SGBV prevalence questionnaire assessing current and 
past experiences of sexual and other forms of violence as survivor or 
perpetrator.
The brief screening questionnaire was incorporated into the facility’s 
existing consent, information, pre-test counselling and screening 
protocol for all VCT clients, adding the following questions: (i) 
whether the patient was seeking testing because they were forced or 
coerced to have sexual intercourse without a condom; and (ii) whether 
they were sexually assaulted/raped. If either (i) or (ii) had occurred, 
the patient was asked when it occurred, whether they had undergone 
a medicolegal examination, whether it had been reported to the police, 
whether the patient received counselling for the incident, and if not, 
whether they would like to receive any of the services inquired about.
The prevalence questionnaire asked patients who had tested 
HIV-positive and were attending adherence training or treatment 
literacy sessions about the prevalence of sexual violence at last 
sexual intercourse and over the respondent’s lifetime, including 
asking for sociodemographic information and about perpetrators of 
violence. The questions relating to experiences of SGBV were guided 
by the WHO’s guided questions on Intersections of Intimate Partner 
Violence. [4] The questions covered the following HIV transmission 
risks: (i) direct transmission through sexual violence; (ii) indirect 
transmission through sexual risk-taking; (iii) indirect transmission 
through inability to negotiate condom use; and (iv) violence as a 
consequence of living with HIV.
Both questionnaires were reviewed and revised by clinic staff and 
piloted. Clinic staff were trained on using the screening instrument 
and the prevalence questionnaire, as well as on eligibility criteria, 
confidentiality and research ethics. Additionally, staff were trained 
on the legal framework for sexual offences and domestic violence (the 
Criminal Law (Sexual Offences and Related Matters) Amendment 
Act 32 of 2007, hereinafter referred to as the Sexual Offences Act, as 
well as the Domestic Violence Act 116 of 1998), including existing 
protocols; the public health, social and structural contexts of sexual 
offences and other forms of gender-based violence; and the referral 
protocol for patients seeking further care or support related to 
current or previous violence. Data collection took place between 
November 2016 and April 2017.
A total of 1 936 clients completed the brief screening questionnaire, 
and 436 completed the in-depth prevalence questionnaire.
Inclusion and exclusion criteria
Inclusion criteria for participation in the screening phase included 
all individuals aged >18 years who attended the clinic for testing 
or counselling services as part of the AHF’s standard protocol, 
after providing informed consent to VCT services. The second 
phase (prevalence questionnaire distributed during treatment literacy 
training) included consenting participants aged >18 years who 
attended the treatment literacy training and took part in psychosocial 
services programmes at the facility.
Data analysis
Descriptive data analysis was done using Stata 13 (StataCorp, USA).
Process of obtaining informed consent
The screening tool was added to the existing AHF pre-testing 
screening protocol. Consent is obtained as an integral part of 
the clinic’s standard of care, in the course of which patients are 
given information on the privacy and confidentiality processes 
effective at the clinic. A separate research consent form was used 
for the prevalence phase of the study. The study was approved by 
the University of Cape Town’s Faculty of Health Sciences Human 
Research Ethics Committee (ref. no. 064/2016). The research protocol 
complies with the South African National Health Act 61 of 2003 and 
with the latest version of the Declaration of Helsinki.[11] 
Results
VCT population: Coercion and sexual violence as 
reason for HIV testing
A total of 1 936 people who came to the health facility for HIV VCT 
were screened. Of these, 1% (n=20) said that they had specifically 
come for VCT because they had been coerced into having sex without 
a condom. Another 1% (n=14) said that they had come for VCT 
because they had experienced sexual violence or been raped.
Treatment literacy population: Sexual behaviour and 
prevalence of forced sex
The 436 participants who had tested HIV-positive and were attending 
treatment literacy classes were interviewed by the clinic psychosocial 
counsellors. The participants’ ages ranged from 18 to 70 years (mean 
32 years), 71% were women, and the majority were single (89%). 
Although 84% had matriculated from high school, only 38% were 
employed (Table 1).
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Table 2 shows the characteristics of participants’ last sexual inter-
course. Of note, 54% had not discussed condom use, and 62% had not 
used a condom. This did not differ between women and men. Sixteen 
percent of male participants had had sex with another man, and 2% 
of female participants had had sex with another woman.
Ten percent of all participants (44/428), and 12% of women 
(35/298), had been forced to have sex the last time that they had 
sexual intercourse, by either a partner or a non-partner. Of those, 7 
had been forced to have sex by more than one person. Table 3 shows 
further details of forced sex at last intercourse.
Treatment literacy population: Lifetime prevalence of 
sexual violence
The lifetime prevalence of sexual violence was 14% among all 
participants who participated in the survey at the treatment literacy 
group. Among female participants, it was 17%: 1 in 6 women. Sexual 
violence perpetrated by intimate partners was the most common 
(lifetime prevalence 9%), followed by sexual violence perpetrated by 
a person known to the participant (lifetime prevalence 7%). Table 4 
provides a detailed analysis of the perpetrators and time periods of 
sexual violence.
Treatment literacy population: Lifetime prevalence of 
physical violence
The lifetime prevalence of physical violence was 16% among all 
participants. Among female participants, it was 19%: almost 1 in 
Table 1. Sociodemographic characteristics of participants in 
treatment literacy training
Age (years), mean (SD) 32.4 (8.9)
Gender (N=434), n (%)
Women 306 (70.5)
Men 128 (29.5)






Level of education (N=370), n (%)
Matric 310 (83.8)
Beyond matric 60 (16.2)
Employment (N=410), n (%)
Not employed 219 (53.4)
Employed 154 (37.6)
Student 37 (9.0)
SD = standard deviation.
Table 2. Characteristics of last sexual encounter
n (%)
Gender of partner, female participants (N=306)
Male partner 299 (97.7)
Female partner 5 (1.6)
Male and female partner 2 (0.7)
Gender of partner, male participants (N=127)
Male partner 20 (15.8)
Female partner 107 (84.3)
Two or more sexual partners
All participants (N=396) 31 (7.8)
Female participants (N=276) 12 (4.4)
Male participants (N=118) 19 (16.1)
Had discussed condom use
All participants (N=428) 196 (45.8)
Female participants (N=300) 142 (47.3)
Male participants (N=126) 53 (42.1)
Did use a condom
All participants (N=431) 165 (38.3)
Female participants (N=301) 116 (38.5)
Male participants (N=128) 49 (38.3)
Table 3. Forced sex at last sexual encounter
n (%)
Forced to have sex by partner
All participants (N=425) 30 (7.1)
Female participants (N=295) 23 (7.8)
Male participants (N=128) 6 (4.7)
Forced to have sex by non-partner
All participants (N=420) 21 (5.0)
Female participants (N=291) 16 (5.5)
Male participants (N=127) 5 (3.9)
Has forced partner to have sex
All participants (N=415) 8 (1.9)
Female participants (N=287) 5 (1.7)
Male participants (N=126) 3 (2.4)
Has forced non-partner to have sex
All participants (N=406) 7 (1.7)
Female participants (N=281) 5 (1.8)
Male participants (N=123) 2 (1.6)
Table 4. Sexual violence: Lifetime prevalence and 
perpetrators
n (%)
Lifetime prevalence of sexual violence
All participants (N=410) 58 (14.2)
Female participants (N=282) 48 (17.0)
Perpetrators of sexual violence, all participants 
Intimate partner
Lifetime prevalence (N=404) 35 (8.7)
In childhood (age <16) (N=395) 11 (2.8)
Since age 16 (N=369) 13 (3.5)
In the past 12 months (N=376) 16 (4.3)
Ex-intimate partner
Lifetime prevalence 10 (2.5)
In childhood (age <16) (N=388) 1 (0.3)
Since age 16 (N=373) 5 (1.3)
In the past 12 months (N=367) 6 (1.6)
Someone known
Lifetime prevalence 27 (6.8)
In childhood (age <16) (N=392) 20 (5.1)
Since age 16 (N=347) 9 (2.6)
In the past 12 months (N=347) 8 (2.3)
A stranger
Lifetime prevalence 12 (3.2)
In childhood (age <16) (N=379) 8 (2.1)
Since age 16 (N=345) 8 (2.3)
In the past 12 months (N=340) 4 (1.2)
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5 women. Like sexual violence, physical violence was most often 
perpetrated by an intimate partner (lifetime prevalence 12%). Table 5 
shows more detailed findings.
Discussion
Our cross-sectional study with two different populations attending 
an HIV health facility in KZN shows that the lifetime prevalence of 
sexual and physical violence experienced by the clinic population 
was high, although seemingly under-reported at the VCT stage. We 
compare our findings with the literature, and discuss the implications 
and recommendations for comprehensive HIV service provision.
Our screening tool showed that only 2% of clients coming for VCT 
said that they came to test because they had been coerced to have 
sex without a condom or had been raped. Both constitute an offence 
under the Sexual Offences Act. This number may seem small until it 
is seen in context: 2% equates to 34 clients over a period of 20 weeks, 
which means that the VCT staff sees more than one patient a week 
for VCT as a result of a sexual assault. This finding has important 
implications for additional SGBV-related support that these clients 
may need, which we address further on.
The prevalence questionnaire, on the other hand, found that 1 in 
10 participants and 1 in 8 female participants had been forced to have 
sex the last time they had sexual intercourse. The lifetime prevalence 
of sexual violence of 14% among all participants and 17% among 
female participants – or 1 in 6 women – also indicates a concerningly 
high rate of SGBV, particularly with regard to levels of sexual violence 
perpetrated by intimate partners (1 in 10). The lifetime prevalence 
of sexual violence among women living with HIV in this study is 
higher than the estimated lifetime prevalence among women in 
the general population (16% among women living with HIV in our 
study, compared with 5 - 12% of women in the general population 
interviewed by Jewkes and Abrahams[12]). Our findings confirm the 
link between SGBV and HIV, through which women are rendered 
more vulnerable to both SGBV and HIV.[4]
There are several potential explanations for the discrepancy 
in SGBV prevalence between the screening tool and the more 
in-depth prevalence questionnaire, some of which raise important 
considerations for identifying SGBV and providing services for 
SGBV survivors in HIV clinical settings. Firstly, the populations 
were different for the two instruments: the in-depth prevalence 
questionnaire was administered to people who were living with 
HIV, while the screening tool was used with all people coming for 
VCT, including those who tested negative. Given the known link 
between SGBV and HIV,[9] we would expect a higher level of SGBV 
experiences in an exclusively HIV-positive population. Secondly, 
research shows that questionnaires that ask more detailed questions 
about violence tend to find higher SGBV prevalence levels.[13] The 
prevalence questionnaire in our study asked much more detailed 
questions than the brief screening tool, which could further explain 
the discrepancy in SGBV prevalence. Lastly, and perhaps most 
importantly, it is very likely that participants’ willingness to disclose 
SGBV experiences depends on their perception of and trust in the 
environment in which they disclose. Participants are more likely 
to disclose SGBV to a counsellor they know and trust (such as the 
counsellors allocated to lead and accompany the treatment literacy 
groups over several weeks), and they are more likely to disclose SGBV 
if they perceive that support and follow-up services are available. This 
again is more likely to be the case among participants who are already 
embedded in the clinic’s psychosocial support services.
While it is well known that sexual offences are under-reported 
in the criminal justice sector, including in South African Police 
Service annual reports on crime statistics, there is a paucity of 
research analysing under-reporting of sexual offences in an HIV 
testing context. There are a number of possible reasons for such 
under-reporting, including: (i) lack of training or mechanisms for 
HIV counsellors to ask about (screen for) SGBV; (ii) the view that 
screening for SGBV is not part of, or important to, the VCT process, 
or beyond the purview of the role of the testing and treatment 
practitioner; (iii) a concern about the ‘cultural appropriateness’ 
of asking questions that are perceived to be ‘a family matter’, or 
too detailed about sexual activity or experiences; (iv) a narrow 
understanding of what constitutes ‘coercive or forced sex’ among 
research participants, or the view that there is no real benefit in 
disclosing SGBV in an HIV testing and treatment environment; and 
(v) after the trauma of a sexual assault, individuals attending HIV 
facilities may prefer to treat just the potential physical outcomes of 
coerced sex rather than the psychological impact of that experience.
Health services, particularly those focused on HIV, provide an 
important entry point for identifying and responding to women who 
have experienced sexual violence, where, for instance, healthcare 
providers can facilitate further services to women for care, treatment 
or support in relation to physical injuries, sexual and reproductive 
health problems associated with violence (e.g. sexually transmitted 
infections, pelvic pain, unwanted pregnancies), or referrals to legal, 
medicolegal or counselling services. The differences in the findings 
between the screening tool and the prevalence questionnaire in our 
study suggest that screening for SGBV may best be done among 
patients who are embedded in an ongoing clinic programme, such 
as treatment literacy training or adherence counselling. The longer-
term linkage to the clinic provides an ideal opportunity for SGBV-
related services, including psychosocial support and specialised 
referrals for further support and treatment. Offering SGBV-related 
services necessitates that all healthcare staff who provide HIV-related 
Table 5. Physical violence: Lifetime prevalence and perpetrators
n (%)
Lifetime prevalence of physical violence
All participants (N=361) 59 (16.3)
Female participants (N=251) 48 (19.1)
Perpetrators of physical violence, all participants
Intimate partner
Lifetime prevalence (N=377) 46 (12.2)
In childhood (age <16) (N=396) 19 (4.8)
Since age 16 (N=375) 26 (6.9)
In the past 12 months (n=375) 24 (6.4)
Ex-intimate partner
Lifetime prevalence (N=362) 16 (4.4)
In childhood (age <16) (N=379) 9 (2.4)
Since age 16 (N=371) 7 (1.9)
In the past 12 months (N=360) 6 (1.7)
Someone known
Lifetime prevalence (N=353) 19 (5.4)
In childhood (age <16) (N=377) 16 (4.2)
Since age 16 (N=350) 6 (1.7)
In the past 12 months (N=353) 6 (1.7)
A stranger
Lifetime prevalence (N=346) 8 (2.3)
In childhood (age <16) (N=369) 4 (1.1)
Since age 16 (N=348) 3 (0.9)
In the past 12 months (N=348) 5 (1.4)
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care (from counsellors to nurses to medical staff) have appropriate 
training on how to identify SGBV, and how to provide support for 
SGBV survivors. In the words of Ellsberg and Betron,[14] ‘providers 
need to be trained to identify women living with violence, and to 
respond with appropriate care and referrals, making sure not to put 
women at increased risk for violence through their actions’.
Conclusions
We recommend that clinic staff follow the WHO clinical and policy 
guidelines for responding to sexual violence against women.[10] Specific 
recommendations for healthcare providers in the SA context include:
• Become familiar with the legal framework, specifically the Sexual 
Offences Act of 2007 and the Children’s Act 38 of 2005, which 
provide definitions of sexual violence and sexual assault and lay 
out legal obligations for healthcare providers.
• Actively seek out existing services for survivors of SGBV in the 
clinic catchment area, to which survivors of SGBV can be referred. 
This should be done together with a social worker, if there is one at 
the clinic. Services are likely to be provided by non-governmental 
organisations, and medicolegal services are available at Thuthuzela 
Care Centres. Building relationships with service providers at these 
centres makes it easier to refer patients for counselling and further 
support.
• Initiate regular and ongoing conversations about SGBV among 
clinic staff, recognising that some of them will be survivors of 
SGBV themselves.
• Challenge attitudes that trivialise or diminish SGBV among 
colleagues and patients, in order to build a respectful and 
encouraging environment for survivors to disclose their 
experiences of SGBV.
Finally, in addition to asking patients about experiences of SGBV, 
health practitioners should ensure that all clinic users know that post-
exposure prophylaxis is available at the facility, how it works and why 
they should access it, through both the consultation process and visible 
messaging within the facility.
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